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Introduction 
Influenza is an acute viral respiratory infection that may result in high morbidity and 
mortality. Worldwide pandemics occur when influenza virus undergoes antigentic shift, 
which involves a reassortment of the segmente R;NA genome of the influenza virus or 
related animal influenza virus in a animal host. The reassortment of the genome may result 
in new hemagglutinin and/or neuraminidase glycoproteins on the viral surface (Janeway et 
al., 2001). The new virus maybe poorly recognized, if at all, by antibodies and T cells in the 
human host directed against the original virus. Thus, most people are highly susceptible to 
the new virus, and severe infection results (Janeway et al., 2001). In the United States 
40,000 — 50,000 deaths occur each year from influenza infection (Smith et al., 1992). A 
greater number of deaths may occur when the virus has undergone antigenic shift. 
Approximately 80-90% of the deaths from influenza occur in the elderly. 
Influenza vaccination is a critical tool for the prevention of the disease. However, 
vaccination is less effective in older adults. The influenza vaccine is only 30-60% effective 
in preventing clinical illness among elderly individuals as compared to 70-90% effective in 
young adults (Gross et al, 1999; Demicheli et al., 2000). 
Immune function is compromised in the aged. That age-related decline of immunity 
may result in poorer vaccine efficacy. The ability to respond effectively when an infection 
occurs also is reduced (Pawelec et al., 1999). The elderly tend to have more severe disease 
symptoms during infectious episodes, which may result in higher in mortality rates (Garg et 
al., 1996). Among older adults, influenza virus infection maybe compounded by secondary 
bacterial pneumonia, leading to higher rates of mortality (Louria et al., 1959). 
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The influenza A virus is highly contagious. It preferentially replicates in the 
epithelial cell layers lining the airway of the respiratory tract, but also can infect 
macrophages and other leukocytes. Most cell types carry the influenza virus receptor, which 
is a sialic acid containing cell surface glycoprotein (Janeway et al., 2001). Productive 
influenza virus infection in epithelial cells leads to the destruction of host cell pre-mRNAs, 
translational inhibition of cellular mRNAs, and death of the host cell by cytolytic or 
apoptotic mechanisms (Julkunen et al., 2001). 
The immune system can respond in many ways to restrict the spread of the virus. 
Cytokines recruit inflammatory cells to the site of infection and activate the host antiviral 
defense system. Th 1 cytokines (IL-2, IFN-y, IL-12 and TNF-a) drive cell-mediated immune 
responses, whereas Th2 cytokines (IL-4, IL-5 and IL-10) are important for B cell growth and 
differentiation and drive humoral immune responses (Shearer et al., 1997). Other defenses 
include activation of apoptotic pathways and antigen presentation by macrophages and 
dendritic cells (Julkunen et al., 2001). 
Several therapies may help improve immune function with advancing age such as 
vitamins, anti-oxidants, hormones, dietary restriction, and exercise. Regular exercise has 
been shown to have mental, physical, physiological, and immunological benefits (Hirokowa 
et al., 1997). In addition to positive effects on immune function, exercise decreases the risk 
of developing heart disease, type II diabetes, osteoporosis, arteriosclerosis, and some types of 
cancer (Mazzeo et al., 1998). Specifically, exercise is now known to have effects on immune 
cells and their function (Woods et al., 2003). Exercise may prevent immunosenescence by 
promoting immune improvement. One 12-week moderate exercise study performed on older 
adult women showed that exercise increased natural killer (NK) activity and T cell function 
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in previously sedentary subjects (Nieman et al., 1993). Another study that compared 
sedentary controls to highly conditioned endurance-trained females (average age 73) found T 
cell function and NK activity was higher in exercise trained individuals (Pedersen et al., 
2000). A study by Guelder et al. showed that T cells from older active women who have 
performed long-term moderate exercise exhibited higher responsiveness (CD25 expression) 
to stimulation in vitro than T cells from a control group of sedentary subjects. Endurance 
training in older males was associated with increased T cell function and cytokine production 
suggesting an attenuation of the age related immune function decline (Shinkai et al., 1995). 
An experiment on aged mice found that exercise training restored the percentages of naive 
and memory cells in the spleen toward that of young mice (Woods et al., 2003). Exercise 
training may have induced apoptosis/necrosis of memory T cells, reduced production of 
memory cells, or cause a reversion of CD44h' expressing cells back to CD44~° expression. 
Kohut et al. (2001) found that exercise was associated with an enhanced production of the 
viral specific Thl-associated cytokines IL-2 and IFN-y in aged mice. To our knowledge, it 
has not yet been demonstrated whether exercise is effective in improving resistance to 
infection among an aged population, and whether any exercise-induced improvement in 
resistance to infection is associated with corresponding enhancement of specific antiviral 
immune defenses. 
The purpose of this investigation was to determine if regular moderate exercise 
training alters immune response to infection with influenza in aged mice. The hypothesis of 
this thesis is that exercise will enhance the immune response to influenza virus infection, as 
evidenced by increased CD80/86 expression and by up-regulation of cytokine production in 
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both the spleen and mediastinal lymph nodes, resulting in attenuated disease and viral load in 
experimentally infected mice. 
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Literature Review 
The elderly population is more susceptible to influenza and has a higher death rate 
than young individuals. An understanding of age related changes in immune function and 
disease susceptibility is necessary to understand the underlying causes of this phenomenon. 
Aging and immunity overview 
Immune senescence is the gradual deterioration in immune function that 
occurs with aging. It is manifested as reduced immune responsiveness measured in vitro and 
as impaired in vivo immune response to acute infection and vaccination. This age related 
decline is largely due to diminished T cell function that adversely affects proliferation, 
cytokine production, and signal transduction (Pawelec et al., 1999). The elderly have an age- 
related decrease in naive T cells and an increase of memory cells. This shift from naive to 
memory cells causes a reduced ability to mount a response to new antigens (Gardner et al., 
2002). Thus, there is an increased risk and severity of infection from new pathogens, such as 
influenza. In addition, the higher percentages of memory cells that are present have a 
significantly reduced ability to recall and respond to previous antigens (Ernst et al., 1993). In 
addition, declining host immune responses, particularly cellular immunity, account for the 
increased susceptibility to influenza virus infection of the aged. Aged mice have been shown 
to have decreased cytotoxic T lymphocyte (CTL) activity against virally infected targets, 
reduced proliferative responses, lower interleukin-2 production, defective antigen 
presentation, and a decreased numbers of splenic precursor cells (Bender et al., 1995). B 
cells and macrophages also function less effectively in the aged (Doppler et al., 1994). Other 
studies have shown diminished natural killer cell (NK) activity in aged individuals compared 
to young individuals (Fiatarone et al., 1989). Increased susceptibility to influenza infection 
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has also been associated with the impaired immune function of T helper 1 cells (Kostense et 
al., 1998) 
In the innate immune system the functions of NK cells, macrophages, and 
neutrophils, decreased with aging (Ginaldi et al., 1999). In the aged mouse, alveolar 
macrophages are decreased in number and are not as efficient at presenting antigen to T cells. 
In addition, more macrophages are needed to effectively activate T cells (Bender et al., 
1995). In addition, neutrophils have impaired chemotaxis, degranulation, and phagocytosis 
(Wenisch et al., 2000). Thus, both the adaptive and innate immune factors decline with age. 
Innate immune defense and aging 
Macrophages, TTK cells, and neutrophils provide the first line of defense against 
bacterial and viral infections. Decline in their function may result in increased incidences of 
bacterial and viral pneumonia and gastrointestinal and skin infections in the aged (Gavazzi et 
al., 2002). In aged mice, splenic and activated peritoneal macrophages express lower levels 
of all toll-like receptors and secrete lower amounts of IL-6 and TNF-a when stimulated 
(bobber et al., 1995). Thus, aging can cause impaired innate defense. 
Shift in naive/memory population 
There is an age-related decrease of naive T cells and an increase of memory cells. 
With increasing age there are fewer naive T cells available to respond to new pathogens and 
an increase in the number of memory CD8+28-57+ T cells (Effros et al., 2000). Age-
associated alterations in naive CD8+ cell function are not found after primary stimulation, but 
may become apparent upon restimulation. This shift from naive to memory cells also causes 
a shift in the cytokine environment (Timm et al., 1999). 
Cytotoxic T cells and aging 
Cytotoxic T lymphocyte (CTL) activity in general and anti-influenza CTL activity 
decrease with age (Fagnoni et al., 2000). Previous studies by Bender et al. (1991) have 
shown that CTL activity is critical for recovery from influenza infection. It has been shown 
that influenza infected nude mice do not clear the infection and shed influenza virus from 
their lungs indefinitely. However, adoptive transfer of CTL to the infected nude mice leads 
to viral clearance from the lungs (Bender et al., 1991). This again suggest that CTL's are 
important in clearance of viral infection. Administration ofanti-influenza antibody to nude 
mice will temporally halt viral shedding as long as the antibody is present. Thus, antibody 
neutralizes the virus and halts it rapid replication but does not completely destroy it. Aged 
mice have a prolonged influenza infection that correlates with lower anti-influenza CTL 
activity, as well as prolonged pulmonary viral shedding (Bender et al, 1993). The cellular 
and molecular basis of the age-related decline in CTL activity have been the subject of 
several studies. Some suggest that with increasing age there is only a slight decline in 
responsiveness of the individual T cell, but a large decline in the number of cells that can 
respond (Bender et al, 1993). It has been demonstrated that aged mice have a lower 
precursor anti-influenza CTL frequency (Effros et al., 1983). Therefore, it appears that CTL 
response to influenza infection is impaired with aging, and this maybe due in part, to a lower 
frequency of CTL specific cells. 
Aging and the Thl/Th2 cytokine balance 
Since the discovery of T helper cell subsets, there have been studies on whether aging 
leads to shifts in the Thl/Th2 response. There are three functional subsets of CD4+ T cells. 
T helper 1 cells (Thl) secrete IL-2, IFN-y, IL-12 and lymphotoxins, which induce cellular 
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immunity against intracellular bacteria and parasites. T helper 2 (Th2) cells secrete IL-4, IL- 
5, IL-10, and IL-13 and promote a humoral response against extracellular pathogens 
(Gardner et al, 2002). Most the circulating CD4+cells are T helper 0, which produce both 
Thl and Th2 cytokines (Janeway et al., 2001). 
During aging, phenotypical and functional changes are seen within murine CD4 T 
cell compartments. Phenotypically, there is a shift from naive CD4+ T cells to memory cells. 
This change is associated with a decrease of IL-2 production and an increase of IL-4 and 
IFN-y production (bobber et al., 1995). 
The ability of B cells to produce particular immunoglobin isotypes depends on 
cytokines produced by CD4 T cells (bobber et al., 1995). CD4 T cells are an important 
source of cytokines. Thus, changes in CD4 T cell populations that occur during aging may 
be responsible for changes in humoral immunity (bobber et al, 1995). 
The same phenomenon is observed in humans. IL-4 and IFN-y production by CD4 T 
cells increases during aging and IL-2 production declines with advancing age. These age- 
associated changes in the cytokine balance may result in altered response to influenza 
vaccine and increased susceptibility to influenza (bobber et al., 1995). 
Immune defense against influenza virus 
Influenza and IFNs 
Interferons (IFNs) protect from virus infection by inducing an antiviral state and 
modulating the immune response (Durbin et al, 2000). There are two distinct families of 
IFNs, IFN-a, -(3 (type I), and IFN-y (type II). IFN-a is largely characterized as inducing a 
"cell-autonomous antiviral state" (Hober et al, 1999). IFN-a is produced by influenza 
infected epithelial cells and by monocytes/macrophages. Using IFN-a, -(3 receptor knockout 
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mice Julkuner et al. illustrated the importance of IFN Type I system in antiviral defense 
against influenza by showing the increased susceptibility to the infection in the knockout 
mice (Julkuner et al, 2001). 
IFN-y is known as an immunomodulator (Durbin et al., 2000). IFN-y is a cytokine 
produced by NK cells, CD4+ Thl cells, and a subset of CD8+ T cells. It is a major defense 
against viruses. It can block viral replication or even lead to elimination of virus by 
promoting killing of infected cells. It stimulates the cellular response by inhibiting the ability 
of some microbes to multiply, and it promotes apoptosis of infected cells (Bot et al., 1998). 
IFN-y can upregulate the presentation of viral peptides in MHC class I molecules of infected 
cells, thus allowing killing of virally infected cells by CTLs (Graham et al., 1996). Other 
effects of IFN-y include upregulation of antigen processing, presentation of MHC class I and 
II, and molecules that regulate priming, recruitment, and death of activated T lymphocytes. 
IFN-y can also increase the function of NK cells and macrophages (Bot et al, 1998). 
Influenza and TNF-a 
Tumor necrosis factor alpha (TNF-a) has multiple functions. It is important in inflammation, 
increases MHC I display on target cells, and boosts CTL killing. In response to influenza, 
TNF-a up-regulates adhesion molecules on endothelial cells ofpost-capillary venules 
causing cell extravasation into the lung (Russel et al., 2001). Studies have found that TNF-a 
may play a role in early neutrophil and eosinophil recruitment by increasing chemokine 
production (McKinney et al., 2003). Other studies show that although TNF-a is increased 
during influenza infection and that anti-TNF-oc administration may actually improve mouse 
survival. These studies suggest that TNF can exacerbate influenza infection by increasing 
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the activation of inflammatory cells. Thus, decreased amounts of TNF could lead to a 
reduction in lung damage to otherwise healthy areas of the lung caused by over-activation of 
inflammatory cells (Hussel et al., 2001). 
Influenza and IL-2 
Studies have shown that baseline concentrations of the T helper 1 cytokine IL-2 
decline with age. Aged mice have been shown to have decreased CTL activity against virally 
infected targets, reduced proliferative responses, lower interleukin-2 production, defective 
antigen presentation, and a decreased number of splenic CTL precursor cells (Bender et al, 
1993). Naive cells have a higher production of IL-2, which is critical in T cell proliferation. 
The decline in IL-2 could be due to the shift from naive to memory cells in an aged 
population. One study reported a diminished proliferative response and decreased IL-2 
production in cell cultures from old mice compared to those from young mice following 
stimulation with influenza virus. Furthermore, they found that addition of exogenous IL-2 
increased the proliferative response of T cells and immunity to influenza (Effros et al., 1983). 
Influenza and IL-12 
There is evidence for diminished natural killer cell activity in aged individuals 
compared to young (Fiatarone, 1987). Endogenous IL-12 contributes to early NK cell- 
dependent IFN-y production (Kostense et al., 1998). IL-12 contributes to the inhibition of 
early virus replication but is not required for virus clearance. IL-12 is important to the 
activation of CTLs and to the development of type I T helper cells (Monteiro et al., 1998). 
IL-12 is a strong inducer of IFN-y, which aids in the differentiation of Thelper 1 cells. It 
induces the maturation of Thl cells and therefore, is important in augmenting cell-mediated 
immunity (Shearer et al., 1997). In influenza infection, IL-12 contributes to the early 
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development and activation of the innate immune responses (Monteiro et al., 1998). 
However, there is conflicting data on the role of IL-12 in influenza. It is possible that IL-12 
plays a role in attenuating the immune response. In a study by Kostense et al. (1998) IL-12 
administration in mice was found to enhance Thl activity but IL-12 delayed recovery from 
influenza. This delay in recovery was due to reduced viral clearance (higher viral titers). 
Thus, IL-12 may have both positive and negative features in response to a viral challenge. 
Costimulatory molecules on APC and influenza infection 
Dendritic cells are considered to be powerful antigen-presenting cells (ADCs). APCs 
are critical to an effective immune response. Dendritic cells destroy pathogens, but more 
importantly they help to mount an adaptive immune response (Janeway et al., 2001). They 
take up antigenic molecules, become activated, and become APCs. Dendritic cells are the 
only APCs capable of priming the lymph node-based naive T cells (Janeway et al., 2001). 
APCs migrate from peripheral sites of pathogen entry to the T cell areas of the lymph node 
where they provide naive T cells with Ag-specific and costimulatory signals. APCs tell the 
immune system the molecular identity and pathogenic potential of an invader (Mailliard et 
al., 2003). Activated dendritic cells secrete cytokines that can affect both adaptive and innate 
immunity. Because dendritic cells are the most powerful APC, their function is critical to 
cellular immunity against influenza (Mailliard et al., 2003). 
In order to proliferate and differentiate in response to a viral challenge, T cells need 
two signals. The MHC bound with antigenic peptide interacting with the TCR gives one 
signal. The other signal is the CD28 costimulatory molecule interacting with B7.1 (CD80) or 
B7.2 (CD86) on APCs (Janeway et al., 2001). Studies have shown that B71 is necessary for 
T cell activation in the lungs (Lumsden et al., 2000). In fact, the T cells stimulatory ability of 
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mouse lung dendritic cells (in vitro) is solely dependent on B7.1 expression whereas B7.2 
has a secondary role (Lumsden et al. 2000). 
Many immune parameters are important in the prevention of, and recovery from 
influenza. However, many of the critical immune mediators are attenuated in aged animals. 
Thus, it is important to find an intervention that can increase immune responsiveness and 
improve resistance to influenza infection. The purpose of this research was to determine the 
effect of moderate exercise on both resistance and immune responsiveness to influenza 
infection in an aged population. We used awell-characterized mouse model of influenza 
infection to determine how exercise affected viral lung titers, lung lesion formation, anti-viral 
cytokine production (IL-2, IL-10, IL-12, IFN-y, TNF-a), dendritic and macrophage 
populations and function. 
The hypothesis of this study was that exercise would enhance resistance to infection. 
Specifically, exercise would decrease lung viral titer, lessen the histopathology by decreasing 
the number and severity of lesions, and would positively affect immunity in regards to viral 
induction of the cytokines TNF-a, IL-2, IL-10, IL-12, IFN-y, and IFN-a. We also 
hypothesize that exercise will up-regulate B7.1 and B7.2 molecule on splenic cells. 
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Materials and Methods 
Animals 
Male BALB/c (n-40) were purchased from Jackson laboratories and allowed to age to 
21-23 months. During that time they acclimated to their environment and a 12-hour light: 12- 
hour dark cycle. Following acclimation, aged mice were randomly assigned to an exercise 
(n=17) or non-exercise (n=17) group. A third group consisted ofnon-exercise uninfected 
control mice (n=4). 
Exercise training 
Mice were trained on a treadmill for 10 weeks. Exercise training started at a 
moderate pace of 6 meters per minute and gradually increased to 14-17 meters per minute for 
45 minutes five times a week during the light phase. The non-exercised and control mice 
were housed in the same place as the exercised mice and exposed to the same noise of the 
treadmill. 
Virus 
A/PR/34/8 (H1N1) influenza virus was grown in chicken eggs. After harvest the 
hemagglutinin titer of the virus was determined. Virus stocks contained 512 
haemagglutinating units (HALE per 0.05 ml. The virus was stored in aliquots at —70°C. 
Prior to use, the virus was thawed in ice and kept on ice. 
Inoculation 
Within 4 hours of exercise, the mice were lightly anesthetized with CO2 and infected 
with approximately 20 HAU of influenza in a volume of 40 µl per mouse via the intranasal 
route. The mice were held for approximately 30 seconds to ensure the virus reached the 
respiratory tract. The intranasal route was chosen to mimic the typical route of entry of 
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influenza infection. After infection, all mice were returned to their original cages with their 
same littermates and symptoms were monitored and recorded daily. Exercised mice were not 
exercised after inoculation. One exercised mouse died 5 days post infection. At necropsy, a 
large tumor unrelated to the influenza infection was observed on the lung. 
Collection of cells and tissue 
Mice were euthanized using a CO2 overdose 6 and 10 days post infection. Blood was 
immediately collected via heart puncture. The thoracic cavity was opened exposing the 
trachea, ribcage and diaphragm. The diaphragm and ribcage were cut away to expose the 
lung. One lobe on the left side of the mouse was clamped off using a small hemostat. This 
lobe was removed and analyzed for influenza viral titer. The remaining lung was inflated 
with formalin though the trachea using a syringe. 
The spleen was removed, placed in a stomacher and crushed into a single cell 
suspension in AIM-V medium. Mediastinal lymph nodes were removed and crushed using 
frosted microscope slides into a single cell suspension in AIM-V medium. 
Histopathology 
The lung lobes were inflated and fixed with formalin using a syringe (with the 
exception of one lobe that was used for viral titer analysis). After inflation, the lungs were 
immersed in formalin. After fixation in formalin for a least one day, each lung lobe was 
trimmed, and embedded in paraffin, and processed into histologic sections by routine 
methods in the Iowa State University Veterinary Pathology Laboratory. Histopatholologic 
evaluation was conducted by a pathologist blinded to the identity of the groups. The number 
of lobes (out of 4) with lesions were recorded. Lesions were graded by estimating the 
percent of involvement for each lobe section. A score of 0= no lesions; 1= 0-25%; 2= 26-
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50%; 3= 51-75%; 4= 76-100%. The average score for the 4 lobes was calculated for each 
mouse. 
Cell cultures 
The splenocytes were drawn up into a pipet and passed through a nylon screen filter 
into a 15 ml centrifuge tube. Hanks Balanced Salt Solution (Sigma Chemical, St. Louis, 
MO) was used to rinse the stomacher bag and the additional cells were also passed through 
the filter into the centrifuge tube. The cells were centrifuged at a speed of 1000 rpm for 5 
minutes and decanted. Approximately 2-3 ml of ice-cold ammonium chloride was added to 
lyse red blood cells and the tube was allowed to sit for 2 minutes followed by the addition of 
10 ml of RPMI. The cells were centrifuged for 5 minutes at 1000 rpm and washed two times 
with Hanks Balanced Salt Solution (HBSS). After the final wash, the cells were resuspended 
in 10 ml AIM-V media (Life Technologies, Grand Island TTY). The cells were counted using 
a Coulter counter (Beckman-Coulter, Hialeah, FL) and the concentration was adjusted to 3 x 
106 cells/ml with AIM-V. 
Cells were incubated for various times with and without the addition of influenza 
virus. One-ml aliquots of cells were placed in a 24-well tissue culture plates. In cultures 
with virus, the A/PR/34/8 Influenza virus stock was diluted 1: 51.2 and 50 µl of virus (10 HA 
units/well) was added to cell cultures before being placed in the incubator. The cell culture 
supernatant collection was as follows: IL-2: 24, 48, 72hr; IFN- y. 48, 72, 96hr; IL-10: 48, 72, 
96hr; TNF-a: 24, 48hr; IL-12: 24, 48, 72hr. IFN-a: 24hr. Tissue culture plates were placed 
in an incubator at 3 7°C and 5 % CO2 for the designated incubation time. 
Optimum virus culture conditions were not obtained. Cells incubated with virus did 
not contain any greater cytokine amounts then the non-virus culture cells. Therefore, the 
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results shown are those of cells incubated in media only. Thus, data for cytokines reflects 
those produced in response to in vivo infection. 
Flow cytometry 
Splenocytes (lml) were aliquoted into 24-well plates with culture media. Splenocytes 
were incubated with live virus (10 HA units/ml) for 24 hours. Five hundred µl of cells and 
10 HA units/well of A/PR/34/8 virus at were added to 2 sterile 12*75mm polypropylene 
tubes per mouse. CDl lc and Mac-1 (CDl lb) (CD80 and CD86 were evaluated). A standard 
flow protocol was followed. Briefly, the cells were washed with cold PBS-0.1% azide and 
stained for 30 minutes with the following antibodies: anti-CDl lc (fluorescein isothiocyanate 
(FITC)), anti-CD80 (B7.1) (phycoerythrin (PE)), anti-CD86 (B7.2) (PE), and Mac-1 (CDllb) 
(FITC) (BD Pharmingen, San Diego, CA). The appropriate isotypes were analyzed as well. 
The results of the Mac 1 and CD 11 c are not shown due to problems gating these populations 
during flow cytometry analysis. 
Mediastinal Lymph nodes 
Mediastinal lymph nodes were collected and put into petri dishes with 1 ml of HBSS. 
The nodes were gently ground using frosted microscope slides and rinsed well with HBSS. 
The cells were passed through a sterile filter screen, placed into a 15 ml tube, and centrifuged 
for 5 minute at 1000 rpm. The cells were washed once with HBSS and resuspended in 500 µl 
of AIM-V media. The cells were counted using a hemocytometer and trypan blue and were 
adjusted to 1x106 cells/ml using AIM-V media. 220u1 of cells and 10 HA units/well virus 
were added to each well in a 96-well plate (for IL-2 and IFN-y ELISA analysis). The cells 
were incubated for 48, 72, & 96 hours at 37°C with 5% CO2. Supernatants were collected 
and stored at —20°C for analysis by ELISA. 
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ELISA 
Commercially available ELISA kits (BD Pharmingen, San Diego, CA) were used to 
determined cytokine concentrations in supernatants from splenocytes or lymph node cultures. 
The cytokines IFN-y, TNF-a, IL-2, IL-10, IFN-a, and IL-12 were measured. 
Virus titer 
Viral titer in the lungs was determined by quantitative Polymerase Chain Reaction 
(Pcx~. 
statistics 
A one-way ANOVA (SPSS software) was used to compare differences in the immune 
parameters (viral titer, lung lesion score, cytokines, CD80/86) between the exercise and 
control group. Day 6 and 10 were compared in separate analyses. In the analyses that 
contained more that one in vitro measure (cytokines at multiple time points in vitro), a one 
way mixed ANOVA (group *time) was used. A one-way ANOVA was also used to 
compare difference in immune responses between the uninfected control mice and the 
infected mice. 
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Results 
Exercise decreased lung pathology and influenza viral titer 
Histopathology 
Lung lesions were graded by estimated percent of lung involvement (graded for each 
lobe and average of all four lobes calculated for each mouse). No lesions were observed in 
any of the control uninfected non-exercised mice. In the group of mice that were euthanized 
at 6 days post infection, six of nine non-exercised mice developed lung lesions (five of 
affected mice had 4/4 lobes affected and an average lobe score of 3.25). Only 3 of 9 
exercised developed lesions with two of those three showing 4/4 lobes affected (average lobe 
score 3.125) (Figure 1). However, the total lesion score (lesions averaged for all mice) was 
not significantly different between non-exercise and exercise mice at day 6. 
In the non-exercised mice that were euthanized at 10 days post infection five often 
mice developed lung lesions. Four of five mice had lesions in 4/4 lobes (average lobe score 
3.06). The average lesion score was significantly lower in exercise mice compared to non- 
exercise mice (p=.05). Only two of the eight exercised mice euthanized at day 10-post 
infection had lesions with 4/4 lobes affected, and with an average lobe score of 2.0 (Figure 
1). Thus, fewer exercised mice developed lesions. Exercised mice that did have lesions had 
less intensive lung involvement. 
Viral Loads 
Virus was not detected in the lungs of uninfected mice. At day 6 the non-exercised 
mice had higher viral titers (p= .006) than the exercised mice (Figure 2a). At day 10 there 
was no significant difference between the exercise and non-exercised mice (Figure 2b). 
19 
Splenocyte Cytokines 
Splenocytes from uninfected mice secreted virtually no TNF-a whereas influenza 
infection resulted in greater production of TNF-a (p=.09) (Figure 3). There was no difference 
between the amount of TNF-a produced by cells incubated for 24 hours in exercised mice 
compared to non-exercised mice at day 6 and 10 days post-infection. However, in a 
comparison between day 6 and day 10, higher amounts of TNF-a were produced at day 10 
(p-value < .001) (Figure 4). 
TL-2 concentrations ranged from very low to undetectable in the uninfected mice. 
Influenza infection appeared to increase the production of IL-2 (p=.1) (Figure 5). Non- 
exercised mice at day 6 produced little to no IL-2 whereas the exercised mice produced 
significantly more IL-2 (p = .O 1). At day 10, there was a statistical trend suggesting that 
splenocytes from exercise mice produced higher amounts of IL-2 the than the non-exercise 
mice (p = .09) (Figure 6). 
There was a trend toward as greater secretion of IL-10 in infected mice compared to 
uninfected mice (p = .08) at 72 hours of in vitro culture (Figure 7). The cells of the exercise 
mice secreted significantly higher amounts of IL-10 than the non-exercised group, at day 6 
post infection (p = .04) (Figure 8). At day 10post-infection the amount of IL-10 produced 
was not significantly different between exercise and non-exercise. 
Figure 9 shows a slight trend toward a difference in the amount of IFN-y produced 
between the uninfected and infected mice (p=.1), with the uninfected mice having low to no 
IFN-y production. At day 6 and 10, there was no significant difference in the amount of IFN-
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y produced by the splenocytes from exercised mice as compared to non-exercise mice (Figure 
10). 
Figure 11 shows no significant difference in IL-12 production between uninfected 
and infected mice at both 24 and 48 hours in vitro culture. There was no difference between 
exercise and non-exercise mice with respect to the amount of IL-12 produced at day 6 or 10 
post-infection (Figure 12 b). 
Splenocytes from infected mice produced significantly more IFN-a than splenocytes 
from uninfected mice (p = .06) (Figure 13). The cells from the exercise group produced 
significantly greater amounts of IFN-a than the control group (p = .OS) (Figure 14). 
Mediastinal Lymph Node Cytokines 
Infection tended to result in higher amounts of IFN-y in the lymph nodes of infected 
mice compared to those of uninfected mice (p = .09) (Figure 15). At day 6 there was a trend 
toward greater IFN-y produced by lymph nodes cells from the exercise group compared to 
the control group (p = .08) (Figure 16). 
Figure 17 and 18 show the amount of IL-2 produced in the mediastinal lymph node. 
There was no significant difference between infected and uninfected mice, or between the 
exercise and non-exercise mice. 
Flow Cytometry 
Influenza infection showed a trend towards increased CD86 expression (p = .09) 
(Figure 19). At day 6, the expression of CD86 expression appeared to be greater in the 
exercise group as compared to the controls (p= .07), but there was no difference at day 10. 
There was no significant difference in CD80 between infected and uninfected mice or 
between the control and exercise mice (Figure 21 & 22). 
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Figure Legend 
Figure 1. Average lesions score of influenza infected mice. Score is calculated from all 
mice from each group whether lesions present or not. Exercise mice have a lower 
lesion scores at day 6post-infection (p= .OS). 
Figure 2. Lung viral titers 6 days post influenza infection in infected non-exercised 
mice and infected exercise mice. At 6 days post infection exercise mice have 
reduced lung viral titers compared to controls (p= .006) (Figure 2a). There is no 
significant difference between viral titers at 10 days post infection (Figure 2b). 
Figure 3. Amount of TNF-a produced by splenocytes in infected and uninfected aged 
mice. Data from day 6 and 10 were combined. Infected mice tended to produced 
more TNF-a than uninfected mice (p= .09). The time points shown are 24 and 48 
hours of in vitro culture. 
Figure 4. Amount of TNF-a produced by splenocytes in infected non-exercise and 
infected exercised aged mice. Day 6 and 10 were analyzed separately. The time 
point shown is 24 hours in vitro culture (Figure 4). No difference between 
exercise and non-exercise was found. 
Figure 5. Amount of IL-2 produced by splenocytes in infected and uninfected aged 
mice. Data from day 6 and 10 were combined. The time points shown are 24 and 48 
hours of in vitro culture. IL-2 tended to be higher in infected mice. 
Figure 6. Amount of IL-2 produced by splenocytes in infected non-exercise and infected 
exercised aged mice. Data from day 6 and 10 were analyzed separately. The time 
point shown is 24 hours in vitro culture. IL-2 production was significantly higher in 
exercise mice compared to non-exercise at 6 days post-infection (p= .O1), whereas a 
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trend toward a higher production of IL-2 by exercise mice was observed at day 10 
post-infection (p= .09). 
Figure 7. Amount of IL-10 produced by splenocytes in infected and uninfected aged 
mice. Data from day 6 and 10 were combined. The time points shown are 72 and 96 
hours. At 72 hours infected mice tended to produce greater IL-10 than uninfected 
mice (p= .08), 
Figure 8. Amount of IL-10 produced by splenocytes in infected non-exercise and infected 
exercised aged mice. Data from day 6 and 10 were analyzed separately. The time 
point shown is 72 hours in vitro culture. IL-10 produced by exercise mice was 
significantly greater than non-exercise mice at day 6post-infection (p= .04). No 
difference between groups was found at day 10. 
Figure 9. Amount of IFN-y produced by splenocytes in infected and uninfected aged 
mice. Data from day 6 and 10 were combined. The time points shown are 72 and 96 
hours. 
Figure 10. Amount of IFN-y produced by splenocytes in infected non-exercise and 
infected exercised aged mice. Data from day 6 and 10 were analyzed separately. 
The time point shown is 72 hours in vitro culture. No difference was found 
between the groups. 
Figure 11. Amount of IL-12 produced by splenocytes in infected and uninfected aged 
mice. Data from day 6 and 10 were combined. The time points shown are 24 and 48 
hours. There was no difference between the groups. 
Figure 12. Amount of IL-12 produced by splenocytes in infected non-exercise and 
infected exercised aged mice. Data from day 6 and 10 were analyzed separately. 
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The time point shown is 24 hours in vitro culture. No difference was found 
between the groups. 
Figure 13. Amount of IFN-a produced by splenocytes in infected and uninfected aged 
mice 6 days post infection. The cells were cultured in vitro for 24 hours in vitro 
culture. Infected mice tended to produce more IFN-a than uninfected mice (p= .06). 
Figure 14. Amount of IFN-a produced by splenocytes in infected non-exercise and 
infected exercised aged mice. Only 6 days post-infection was evaluated. The 
time point shown is 24 hours in vitro culture. Exercise mice produced 
significantly more IFN-a than non-exercise mice (p= .OS). 
Figure 15. Amount of IFN-y produced by mediastinal lymph node cells of influenza 
infected and uninfected aged mice. Data from day 6 and 10 were combined. The 
cells were cultured in vitro for 72 hours. Infected mice tended to produced 
greater IFN-y than uninfected (p= .09). 
Figure 16. Amount of IFN-y produced by the mediastinal lymph node cells in infected 
non-exercise and infected exercised aged mice. Data from day 6 and 10 were 
analyzed separately. The time point shown is 72 in vitro culture. At day 6 post- 
infection IFN-y production tended to be higher in exercise than non-exercise mice 
(p= .08). There was no difference between groups at day 10. 
Figure 17. Amount of IL-2 produced by mediastinal lymph node cells of influenza 
infected and uninfected aged mice. Data from day 6 and 10 were combined. The 
cells were cultured in vitro for 48 hours. No difference was found between 
groups. 
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Figure 18. Amount of IL-2 produced by the mediastinal lymph node cells in infected 
non-exercise and infected exercised aged mice. Analyzed 6 and 10 days post 
infection separately. The time point shown is 48 in vitro culture. No difference 
was found between groups. 
Figure 19. The percent of splenic cells expressing CD86. Infected mice tended to 
demonstrate greater expression of CD86 then uninfected (p= .09). 
Figure 20. Percent of splenocytes expressing CD86 in infected non-exercise and infected 
exercise. At day 6, CD86 expression tends to be greater in exercise mice compared to 
non-exercise mice (p= .07), whereas there is no difference at day 10. 
Figure 21. The percent of splenic cells expressing CD80. Uninfected mice were compared to 
infected mice with respect to CD80 expression. There was no difference between the 
goups. 
Figure 22. Percent of splenocytes expressing CD86 in infected non-exercise and 
infected exercise. Data from day 6 and 10 were analyzed separately. There was 
no difference between the groups. 
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Discussion 
As we expected, infection of mice with the influenza virus led to a histopathological 
picture characterized by an accumulation of inflammatory cells and destruction of respiratory 
epithelium (Bender, 1995). Our results showed that exercise mice developed fewer lesions 
and the lesions that developed were less severe than in the control mice. These findings 
suggest that moderate exercise training has beneficial effects in terms of reducing the 
pathology associated with influenza infection. We also observed that exercise reduced the 
viral titer at day 6post-infection. Although it is possible that viral titers were also 
diminished in the exercise group at earlier time points (prior to day 6), we did not evaluate 
earlier time points in this experiment. Our preliminary studies suggested that lung viral titers 
appeared to peak near day 3-4 post-infection and begin to decline by day 6post-infection. 
To our knowledge, this is the first study to demonstrate that exercise training in an aged 
population can reduce the severity of viral infection. 
We also observed that exercise training affected both nonspecific and specific 
immune defenses during viral infection. IFN-a is an important innate defense against viral 
infection, and we found that IFN-a was significantly increased with exercise. This maybe 
one reason for the decline in lung viral titer, although we will need to measure IFNa at 
earlier time points in the lung to confirm this. 
There was also an increase in splenocyte TNF-a production in response to influenza 
infection, particularly at day 10. To our knowledge, this delayed increase of TNF-a is the 
spleen in response to influenza infection has not previously been shown. TNF-a is critical to 
cell recruitment and up-regulates adhesion molecules on endothelial cells of venules, leading 
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to cell influxes into the lung. However, we found that there was no significant difference 
between the exercise and non-exercise groups at the time points measured. 
IFN-y is an inflammatory cytokine that helps to recruit immune cells to the site of 
infection. B augarth and Kelso (1996) have shown that anti-IFN-y antibody given to 
influenza infected mice drastically reduced the cells that infiltrated the lungs. Therefore, it 
seems possible that higher amounts of virally induced pulmonary IFN-y are related to 
increased inflammation. However we did not measure pulmonary IFN-y and therefore, we 
cannot determine whether exercise has an effect on lung IFN-y. IFN-y is an TH 1 cytokine 
that promotes up-regulation of CTL function. In the draining lymph node to the infection 
IFN-y tended to increase in the exercise mice at day 6 suggesting improved CTL function 
early in the infection. 
A strong immune response to influenza requires a "complex interplay" between 
CTLs, antibody secreting B cells, and cytokine secreting CD4 cells (Gerhard, 2001). IL-2 is 
a immune system messenger which is involved in the proliferation of CD4 cells. CD4 cells 
contribute to immune responses at the site of infection by secreting cytokines (Brown et al, 
2004). Depletions studies have shown that CD4 cells are also required to provide help for 
CTLs and B cells (Mozdzanowska et al, 2000). Exercise training significantly increased IL-2 
production 6 days post infection. This may suggest that the increased IL-2 production in 
exercise mice enhanced antiviral defenses (CTLs, B cells, and CD4 proliferation). 
We did not find a difference in IL-12 production between exercise and non-exercised 
mice. Previous studies demonstrated potential adverse consequences of IL-12 
administration. Mice injected with IL-12 were found to have delayed viral clearance, 
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increased mortality, and higher amounts of pulmonary inflammation. The researcher 
suggested this was due to higher amounts of induced pulmonary IFN-y correlated with the 
IL-12 treatment (Kostense 1998). High amounts of IL-12 could lead to increased disease 
severity by activating bystander inflammatory cells, thus damaging otherwise healthy areas 
o f the lung. 
Other studies have shown that IL-12 is important in early activation of the immune 
response in influenza infection through early induction of IFNy, subsequently leading to an 
inhibition of early virus replication and the activation of CTL's. It has been suggested that, 
as the immune response progresses, it becomes more antigen driven and IL-12 is no longer 
needed. Thus, the mice are able to recover from influenza virus without IL-12 (Montessori 
1997). It maybe helpful in future studies to examine IL-12 production early in infection 
perhaps in the lungs and determine whether exercise may influence IL-12 potentially 
resulting in early activation of the immune response. 
The CD28 costimulatory pathway is crucial for T cell activation. A study by 
Lumsden et al (2000) found that blocking the interaction of CD28 with CD80 and CD86 in 
influenza infected mice reduced virus-specific cytotoxicity, IFN-y production, virus specific 
CD8+ cells, and resulted in lower virus-specific antibody titers. In this experiment the mice 
were still able to clear the virus, but viral clearance was delayed in comparison with controls. 
The researchers also found that blocking only the CD80 ligand did not affect immunity as 
long as the CD86 ligand was still able to bind to CD28 (Lumsden et al., 2000). This could 
explain why we observed no difference between infected and uninfected mice with respect to 
the expression of CD80. We found that the expression of CD86 cell populations tended to be 
greater in infected mice compared to uninfected mice. Also, at 6 days post-infection, there 
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was an increase of the percent of cells expressing CD86 in the exercise trained mice 
compared to non exercise mice. Higher percent of CD86+ cells maybe suggestive of a 
greater number of antigen presenting cells, potentially leading to better antigen presentation. 
In addition, higher CD86 expression could suggest that there is an upregulation of specific T 
cells. 
The mechanisms by which exercise alters immune responses are not clear. However, 
it is known that physical activity can influence neuroendocrine levels in the central nervous 
system and in peripheral blood. Changes in immune function that occur in response to 
exercise maybe regulated by various neurohormones. Neuropeptides altered by exercise that 
may affect the immune system include sertonin, substance P, and vasoactive intestinal 
peptide (Pedersen et al., 2000). ~3-endorphin is an opioid peptide released during exercise that 
can also affect immune function. Studies have show that (3-endorphin enhances NK cell 
activity and IFN production in vitro. It has also been shown to regulate macrophage, T and B 
cell functioning (Jonsdottir et al., 2000). It is possible that the release of (3-endorphin during 
exercise acts to enhance immune function. 
(3-adrenoreceptors are present on many immune cells such as T and B-lymphocytes, 
neutrophils, macrophages, and NK cells. Cells respond to catecholamines via (3-adrenergic 
receptor activation. Catecholamines increase during exercise and have numerous effects on 
immune cell function (Madden et al., 2000). In a recent three-week mouse exercise training 
study by Itoh et al. found that exercise down-regulates (3-adrenergic receptor expression 
resulting in enhanced immune responsiveness. This decline ~i-adrenergic receptor expression 
improved IL-12 induced type 1 helper T cell mediated immune responses (Itoh et al., 2004). 
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Overall, we observed beneficial immunological responses with exercise training that 
may have led to the reduction in viral burden and inflammatory pathology. We tended to 
find an up-regulation of cytokine secretion early in the infection (day 6) which may have 
improved resistance to the infection and enhanced viral clearance. This increase was 
observed both in the draining lymph nodes and the spleen. Also, APC function may have 
been improved by exercise, as suggested by the up-regulation of CD86 expression. In many 
instances we observed enhanced immune response to influenza in the exercise mice at day 6, 
but not at day 10. This suggests that exercise training may shift the kinetics (timing) of the 
immune response by up-regulating immune defenses more rapidly. 
Therefore, our results suggest that exercise maybe an effective method of improving 
resistance to viral infection in the aged, and numerous immune responses (both innate and 
adaptive) appear to be enhanced by exercise. 
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